Shah Humam, Khan Naveed Ahmed, Ullah Muhammad Imran, Khan Umer Zaryab, Irfan Uzair, Ahmad Iftikhar
Khyber Medical College, Peshawar, Pakistan.
Department of Gastroenterology, Hayatabad Medical Complex, Peshawar, Pakistan.
J Gastrointest Cancer. 2025 Sep 13;56(1):188. doi: 10.1007/s12029-025-01314-9.
Colorectal cancer (CRC) often involves liver. However, the standard treatment for CRC with liver metastases (CRC-LM) is debatable. This meta-analysis compares the efficacy of ablation with surgical resection in CRC-LM patients.
A systematic literature search was conducted in PubMed, ClinicalTrials.gov and Cochrane Library. Studies published during January 2020 to February 2025 and comparing any form of ablation with surgical resection in adult patients with CRC-LM were included. The primary outcomes were overall survival (OS), disease-free survival (DFS), while the secondary outcomes were recurrence patterns, length of hospital stay, and complication rates.
A total of 15 studies were included in the meta-analysis. The pooled analysis revealed a significant difference in OS favoring surgical resection (RR: 0.82, 95% CI: 0.73, 0.92, p = 0.001, I = 33%), while DFS showed no significant difference between the groups (RR: 0.76, 95% CI: 0.38, 1.53, p = 0.44, I = 85%). Hospital stay was significantly shorter in the ablation group (MD -1.44; 95% CI -2.18,-0.69; p = 0.0001; I = 97%), and the rate of major complications was also significantly lower with ablation (RR 0.26; 95% CI 0.18-0.38; p < 0.00001; I = 0%). Additionally, ablation and resection were comparable in terms of both local recurrence (RR 1.27; 95% CI 0.86-1.86; p = 0.23; I = 38%) and appearance of new lesions (RR 0.98; 95% CI 0.75-1.29; p = 0.90; I = 9%).
Surgical resection offered superior OS compared to thermal ablation for CRC-LM patients. However, thermal ablation was associated with shorter hospital stay and fewer major complications, highlighting its value as a less invasive alternative in selected patients.
结直肠癌(CRC)常累及肝脏。然而,结直肠癌伴肝转移(CRC-LM)的标准治疗方法存在争议。本荟萃分析比较了消融术与手术切除在CRC-LM患者中的疗效。
在PubMed、ClinicalTrials.gov和Cochrane图书馆进行了系统的文献检索。纳入2020年1月至2025年2月期间发表的、比较任何形式的消融术与手术切除在成年CRC-LM患者中的研究。主要结局为总生存期(OS)、无病生存期(DFS),次要结局为复发模式、住院时间和并发症发生率。
荟萃分析共纳入15项研究。汇总分析显示,在OS方面,手术切除具有显著优势(RR:0.82,95%CI:0.73,0.92,p = 0.001,I = 33%),而两组间DFS无显著差异(RR:0.76,95%CI:0.38,1.53,p = 0.44,I = 85%)。消融组的住院时间显著缩短(MD -1.44;95%CI -2.18,-0.69;p = 0.0001;I = 97%),消融术的主要并发症发生率也显著更低(RR 0.26;95%CI 0.18 - 0.38;p < 0.00001;I = 0%)。此外,在局部复发(RR 1.27;95%CI 0.86 - 1.86;p = 0.23;I = 38%)和新病灶出现(RR 0.98;95%CI 0.75 - 1.29;p = 0.90;I = 9%)方面,消融术与切除术相当。
对于CRC-LM患者,手术切除在OS方面优于热消融术。然而,热消融术与较短的住院时间和较少的主要并发症相关,凸显了其在特定患者中作为一种侵入性较小的替代方法的价值。